The morphology of tumors formed by KRAS intact KC/KPC cells resembled moderately differentiated adenocarcinomas, whereas loss of KRAS resulted in poorly differentiated neoplasms (Fig. 1e). This evidence concerns the gene KRAS and adenocarcinoma.